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China’s new leadership has been on board recently and they will face a great challenge, how to control the spread
of HIVAIDS in China. Recent studies have shown that sexual transmission has become the main route of HIV spread
in China. Therefore, more strong and effective measures have to be taken to protect people from HIV infection via
sexual transmission in order to reduce the mortality and morbidity of HIV infection and AIDS in China.During the week of World AIDS Day 2012, Mr. Li
Keqiang, Chinese Vice-Premier and key member of
China’s new leadership, warned that controlling the
spread of HIV/AIDS remains a serious public health
problem, stating that it is “not only a medical issue, but
also a social challenge.” Under these circumstances, con-
trol over this epidemic requires cooperation between both
government groups and non-governmental organizations
(http://news.xinhuanet.com/english/bilingual/2012-11/29/
c_132007520.htm).
By the end of October 2012, a total of 492,191 HIV/
AIDS cases had been reported on the mainland of
China, even though the government’s estimation is much
higher at 780,000. While, nationally, the prevalence of
HIV/AIDS remains low, the epidemic has become severe
in some areas and among some populations [1].
The Chinese government has implemented much stron-
ger commitment to HIV/AIDS prevention since 2003 by
accelerating strategic planning and scaling-up the initia-
tives to conduct HIV testing and control the epidemic
in high-risk groups, including injection drug users, sex
workers, men who have sex with men (MSM), and plasma
donors, as well as providing treatment for infected indi-
viduals [2]. As a result, a significant reduction of the inci-
dence of HIV transmission has occurred among injection
drug users and blood donors. Also, the rate of mother-
to-child transmission of HIV has plunged from 34.8% in
2007 to 7.4% in 2012 (http://news.xinhuanet.com/english/
bilingual/2012-11/29/c_132007520.htm).* Correspondence: Shibojiang@fudan.edu.cn
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arisen in recent years. Namely, the proportion of re-
ported HIV/AIDS cases involving homosexual and hetero-
sexual transmission has climbed successively each year
since 2004 (Figure 1) [3]. For example, the reported cases
resulting from HIV sexual transmission increased from
33.1% in 2006 to 76.3% in 2011 [1]. From January to
October of 2012, China reported 68,802 new HIV/AIDS
cases, and about 85% of them represented infection
through sexual contact, including 21% through MSM.
Therefore, sexual transmission has become the main route
of HIV spread in China [1].
An even more ominous sign is the current spread
from high-risk populations to the general population [3],
especially the married women. Thus, greater attention
should be paid to those women, in addition to the high-
risk populations. A survey indicates that 30.5% of males
soliciting sex with female prostitutes consistently use con-
doms, while consistent condom usage with their spouses
is only 3.5% [4]. Most married women have established a
degree of trust which seems to obviate the need to take
preventive measures when engaging in sexual intercourse
with their husbands. However, some of their spouses may
also have had sex with prostitutes, and, as a consequence,
may pass on the viruses.
Besides condom use, other effective means, including
public education and intervention, are also important for
preventing HIV sexual transmission. A number of Chinese
central government departments have implemented infor-
mation, education and communication (IEC) plans. As a
results, some success in educating the public has been
demonstrated, as indicated by a 2010 study showing that
the levels of basic awareness of HIV among young studentstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Breakdown of the newly reported HIV/AIDS cases by year and transmission route [adapted from [1]].
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[1]. Overall, the Chinese government, in collaboration with
disease control bodies, medical treatment facilities and
community-based organizations, has strengthened its in-
tervention program among the high-risk populations, espe-
cially among prostitutes and MSM, in order to reduce the
sexual transmission of HIV. Data from the national senti-
nel surveillance indicate that intervention among sex
workers increased from 74.3% in 2009 to 81.0% in 2011,
and among MSM, it increased from 75.1% in 2009 to
76.7% in 2011 [1].
The treatment-as-prevention is a very promising ap-
proach against HIV sexual transmission. Most recently,
Jia et al compared the annual rate of HIV infection in
HIV-negative individuals who had sex with treated or
treatment-naive HIV-positive partners. They found that
the antiretroviral treatment resulted in an overall 26%
reduction in HIV transmission, suggesting that antiretro-
viral therapy prevents HIV transmission among hetero-
sexual, serodiscordant couples [5].
Microbicides are antimicrobial medications formulated
as a gel, cream, suppository, or intravaginal ring for vagi-
nal (or rectal) administration, to prevent the sexual trans-
mission of HIV [6]. A clinical trial conducted in South
Africa has shown that a microbicide gel containing 1%
Tenofovir, an anti-HIV drug, is 39% effective at preventing
sexual transmission of HIV to women during sex with
HIV-positive male partners [7]. It is expected that such
microbicides will play an increasingly critical role in the
prevention of HIV sexual transmission in the near future.
However, development of anti-HIV microbicides has been
remarkably neglected in China. Before 2008, no major
funding supported microbicide development in China. In
2009, four projects did receive funding from the Ministry ofHealth and Ministry of Science and Technology of P. R.
China. However, the total budget for 2010 and 2011 was
only 3.6 M USD, while the U.S. National Institutes of Health
provided 147 M USD to support microbicide development
for the same period (http://www.hivresourcetracking.org).
So far, no safe and effective microbicide has been ap-
proved for clinical use in the world. However, in China,
several so-called “microbicides” have been on the market
for several years. These “microbicides” contain surfactants,
such as nonoxynol-9 (N-9), octoxynol-9 (also known as
Triton X-100) or benzalkonium chloride (BZK). Although
these chemicals are effective in killing viruses in vitro, they
can be toxic to the vaginal mucosa in vivo. Clinical trials
have shown that N-9 does not reduce HIV risk, but actu-
ally increases it [8]. We pointed out this problem in 2006
[9], but we have seen no progress in solving it.
HIV/AIDS studies have historically been hampered by
an overly cautious biosafety policy executed in China,
which requires that samples containing live HIV must be
handled in a BSL-3 facility (http://www.lncdc.com/fgbz/
gzfa/rjcybyml.doc). However, in the United States and
many other countries, the experiments using research-
laboratory-scale quantities of HIV, like HBV and other
blood-borne viruses, can be performed in a BSL-2
facility (http://www.cdc.gov/biosafety/publications/bmbl5),
because HIV is not a dangerous airborne virus that must
be handled in BSL-3 facilities. Because of a limited num-
ber of BSL-3 facilities located in a few big cities and be-
cause of the high cost of using a BSL-3 facility, most HIV/
AIDS researchers cannot carry out their key experiments
using live HIV virions. Consequently, if live HIV is needed,
a number of research projects must be discontinued.
Therefore, we suggest that this policy be revised so that the
researchers in China can handle research-laboratory-scale
Jiang et al. Cell & Bioscience 2013, 3:17 Page 3 of 3
http://www.cellandbioscience.com/content/3/1/17quantities of HIV in BSL-2 facilities as described by the US
CDC (http://www.cdc.gov/biosafety/publications/bmbl5).
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